Applied DNA Sciences, Inc. Introduces Breakthrough Anti-Counterfeit DNA-Embedded Ink Technology to North America and Europe.
LOS ANGELES--(BUSINESS WIRE)--June 4, 2003
Applied DNA(TM) Ink technology to be an effective deterrent to the
increasing number of sophisticated worldwide counterfeiters
Applied DNA Sciences, Inc. (OTCBB:APDN), a provider of proprietary DNA-embedded security solutions that protect corporate and government intellectual property from counterfeiting and fraud, today announced the introduction of the DNA-embedded ink technology in the Northern American and European markets. With applications for a wide range of consumer and industrial products, Applied DNA(TM) Ink technology is an effective deterrent to the increasing number of sophisticated worldwide counterfeiters. Products that utilize any form of ink can be protected with Applied DNA Ink technology, which is cost-effective and can be used in any company's branding, product tracking, or anti-counterfeiting program.
This proprietary biotechnology, scientifically processed DNA Ink, utilizes plant DNA and is processed so that it contains a unique and specific authentication code for each manufacturer. The DNA-embedded ink can be applied to garment labels, printed onto logos, documents, currency, and a multitude of other printed media, or on any other surface. The printed media can then be tested for authenticity.
Applied DNA Sciences' anti-counterfeit Applied DNA Ink technology has been developed with two major components. The first is a uniquely stable and environmentally tolerant covert anti-counterfeit ink, which can be authenticated by laboratory DNA analysis. The second is an ink technology with a proprietary technique that allows for on-site, real time authentication, using the "instant detection" feature of the DNA Ink. This instant verification process has been designed to quickly allow sampling at any point in the product supply chain. By applying a specifically matched testing buffer fluid across an authentic Applied DNA Ink surface, a biochemical reaction occurs between the coating of the DNA ink molecules in the ink and the buffer fluid. This reaction manifests as a reversible color change, with the ink changing color from "blue to pink," and back from "pink to blue" within seconds.
Applied DNA Sciences is able to create groups of DNA codes that are embedded into inks that become a unique and traceable tag or marker for any imprinted product. The propriety process structures plant DNA molecules that are treated to withstand environmental conditions (such as UV light, heat, solvents, etc.) that would otherwise cause DNA molecules to disintegrate. The specially processed DNA molecule is stable for over 100 years. Anti-counterfeit DNA ink is extremely difficult to copy or counterfeit due to the specificity of DNA sequences and the minute amounts of ink. In addition, the DNA concentration in the media is extremely low, which makes the DNA sequence unlikely to be detected by cloning methods.
About Applied DNA Sciences, Inc.
Applied DNA Sciences, Inc. provides proprietary DNA-embedded security solutions that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, and unauthorized intrusion. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. (http://www.biowell.com.tw/eng/home.htm) of Taiwan. The company develops, markets, and sub-licenses DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences' technology addresses the more than $350 billion of counterfeit products sold each year as well as the multi-billion dollar homeland security market. The company is headquartered at 9255 W. Sunset Blvd., Los Angeles, CA 90069; Tel: 310.860.1362; Fax: 310.860.1303 or visit www.ADNAS.com.
The statements made by Applied DNA Sciences, Inc. (the Company) may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe the Company's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA Sciences, Inc. Actual results could differ materially from those projected due to changes in interest rates, market competition, changes in the local and national economies, and various other factors. The Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
|Printer friendly Cite/link Email Feedback|
|Date:||Jun 4, 2003|
|Previous Article:||Avici Systems and Huawei Technologies Sign Agreement to Deliver Next-Generation IP Solutions.|
|Next Article:||Disc Marketing CEO Tena Clark, Speaking at Women's Business Conference at Santa Clara University, Releases Results of First-Ever Study Measuring...|